Batanopride (BMY-25801): a new 5-HT3 receptor antagonist for the prevention of cancer chemotherapy-induced emesis.

Smaldone, L; Plezia, P; Alberts, D; Aapro, M; Sartiano, G; Dorn, M; Brady, M; Comerski, C; Schwartz, S E; Fairchild, C

Smaldone, L; Plezia, P; Alberts, D; Aapro, M; Sartiano, G; Dorn, M; Brady, M; Comerski, C; Schwartz, S E; Fairchild, C.

Affiliation

Smaldone L; Bristol-Myers Squibb, Pharmaceutical Research Institute, Wallingford, CT 06492-7660.

Cancer Treat Rev ; 17(2-3): 319-27, 1990 Sep.

Article in En | MEDLINE | ID: mdl-2272047

Subject(s)

Antiemetics; Antineoplastic Agents/adverse effects; Metoclopramide/analogs & derivatives; Neoplasms/drug therapy; Serotonin Antagonists; Vomiting/prevention & control; Animals; Antiemetics/pharmacokinetics; Antiemetics/therapeutic use; Cisplatin/adverse effects; Dogs; Dopamine Antagonists; Female; Ferrets; Hemodynamics/drug effects; Humans; Male; Metoclopramide/pharmacokinetics; Metoclopramide/pharmacology; Metoclopramide/therapeutic use; Mice; Middle Aged; Rats; Serotonin Antagonists/pharmacokinetics; Serotonin Antagonists/therapeutic use; Vomiting/chemically induced

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Serotonin Antagonists / Vomiting / Metoclopramide / Antiemetics / Neoplasms / Antineoplastic Agents Limits: Animals / Female / Humans / Male / Middle aged Language: En Journal: Cancer Treat Rev Year: 1990 Document type: Article Country of publication: HOLANDA / HOLLAND / NETHERLANDS / NL / PAISES BAJOS / THE NETHERLANDS

Search on Google

Add to My VHL

XML

PubMed Links